|
Dr. Minocherhomjee joined William Blair & Company in 1992 as a senior health care analyst after spending five years at two other investment firms. As head of the firm's health care research group, Dr. Minocherhomjee covered several sectors, including drugs/drug delivery, medical devices and selected health care services. He was a Wall Street Journal All Star Analyst in both medical device and pharmaceutical sectors. Selected current and past portfolio directorships include: Atherogenics, Inc., CryoCor, Inc., Cypress Medical Products, DJ Pharma, Inc., Inhibitex, Inc., Morton Grove Pharmaceuticals, NuVasive, Inc., PharmaResearch Corporation, POINT Biomedical, Proteome, Inc., and ZYCOS, Inc. Dr. Minocherhomjee received an MS (Pharmacology) from the University of Toronto and a Ph.D and an MBA from University of British Colombia, and was a post-doctoral fellow in pharmacology at University of Washington Medical School. | 